Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Comparison of Combined ACB and IPACK Versus ACB Alone for Postoperative Pain Management After ACL Reconstruction

18 de novembro de 2026 atualizado por: Kazi Mahzabin Arin, Bangladesh Medical University

Evaluation of Combined Adductor Canal Block and Infiltration Between the Popliteal Artery and Capsule of the Knee (IPACK) Block Versus Adductor Canal Block (ACB) Alone on Postoperative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction-A Randomized Controlled Trial

This randomized controlled trial aims to evaluate whether combining an adductor canal block (ACB) with an infiltration between the popliteal artery and the knee capsule (IPACK) provides better postoperative analgesia than ACB alone in patients undergoing anterior cruciate ligament reconstruction.

A total of 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II will be randomly allocated into two groups. The intervention group will receive ultrasound-guided combined ACB and IPACK blocks, while the comparator group will receive ultrasound-guided ACB alone. Both groups will receive spinal anesthesia and standardized postoperative analgesia.

Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS) at 2, 6, 12, and 24 hours after surgery. Other outcomes will include total opioid consumption during the first 24 hours, postoperative quality of recovery assessed by the QoR-15 questionnaire, time to first rescue analgesic request, maximum walking distance, and block-related complications.

The findings are expected to provide evidence on the effectiveness of adding an IPACK block to ACB to improve postoperative pain management following ACL reconstruction.

Visão geral do estudo

Descrição detalhada

Anterior cruciate ligament reconstruction (ACLR) is a commonly performed orthopedic procedure for patients with anterior cruciate ligament injuries. Despite its minimally invasive arthroscopic approach, the procedure is frequently associated with significant postoperative pain due to surgical tissue injury, graft harvesting, tourniquet application, and postoperative inflammatory responses. Inadequate pain management may interfere with early mobilization, delay rehabilitation, increase opioid consumption, and negatively affect postoperative recovery.

Effective postoperative analgesia is therefore an important component of perioperative care following anterior cruciate ligament (ACL) reconstruction. Multimodal analgesia, including regional anesthesia techniques, is increasingly used to improve pain control while minimizing opioid-related adverse effects.

The adductor canal block (ACB) is an ultrasound-guided regional anesthesia technique that primarily targets the saphenous nerve and provides analgesia to the anterior and medial aspects of the knee while generally preserving quadriceps muscle strength. However, adductor canal block (ACB) alone may provide inadequate analgesia for pain originating from the posterior aspect of the knee.

The infiltration between the popliteal artery and the knee capsule (IPACK) block is an ultrasound-guided regional anesthesia technique designed to provide analgesia to the posterior knee capsule while minimizing motor blockade. Combining infiltration between the popliteal artery and the knee capsule (IPACK) with adductor canal block (ACB) may provide more comprehensive postoperative analgesia by addressing both anterior-medial and posterior knee pain.

The present randomized controlled trial is designed to evaluate the effectiveness of combined ultrasound-guided adductor canal block (ACB) and infiltration between the popliteal artery and the knee capsule (IPACK) blocks compared with ultrasound-guided adductor canal block (ACB) alone in patients undergoing arthroscopic anterior cruciate ligament reconstruction.

The study will include 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II who are scheduled for anterior cruciate ligament (ACL) reconstruction. Participants will be recruited using consecutive sampling and randomly allocated 1:1 to two study groups using computer-generated block randomization. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. The outcome assessor will remain blinded to the group allocation.

Participants allocated to this group will receive an ultrasound-guided adductor canal block with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided IPACK block with an additional 20 mL of 0.25% bupivacaine.

Participants allocated to this group will receive ultrasound-guided adductor canal block alone using 20 mL of 0.25% bupivacaine.

Both groups will undergo surgery under standard spinal anesthesia. Standardized postoperative analgesia will be provided using intravenous paracetamol (15 mg/kg) every 8 hours. Rescue analgesia with intravenous morphine (3 mg) will be administered when the postoperative Numeric Rating Scale (NRS) pain score exceeds 5, with repeat administration if required.

The study findings will help determine whether adding an IPACK block to an adductor canal block provides improved postoperative analgesia compared with ACB alone following ACL reconstruction.

Tipo de estudo

Intervencional

Inscrição (Estimado)

72

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Dhaka, Bangladesh, 1000
        • Bangladesh Medical University
        • Contato:
        • Investigador principal:
          • Mosharof Hossain, MD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 50 anos (Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Patient with anterior cruciate ligament injury requiring surgery.
  • Adult patients
  • Patients aged between 18 and 50 years
  • BMI
  • Patients of either sex.
  • American Society of Anesthesiologists (ASA) physical status I-II.

Exclusion Criteria:

  • Known allergy to local anesthetic drugs
  • Coagulopathy or patients receiving anticoagulant therapy
  • Infection at the site of injection
  • Chronic opioid use or opioid dependence
  • Pregnancy

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Group IPACK+ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided infiltration between the popliteal artery and the knee capsule (IPACK) using an additional 20 mL of 0.25% bupivacaine. Both blocks will be administered before surgery. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Participants will receive an ultrasound-guided combined adductor canal block (ACB) and an infiltration between the popliteal artery and the knee capsule (IPACK) before surgery. The ACB will be performed using 20 mL of 0.25% bupivacaine administered around the saphenous nerve in the adductor canal. The IPACK block will be performed using an additional 20 mL of 0.25% bupivacaine injected into the interspace between the popliteal artery and the posterior capsule of the knee under ultrasound guidance. Both blocks will be administered as a combined regional anesthesia technique for postoperative pain management following anterior cruciate ligament reconstruction.

Comparador Ativo: Group ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) alone using 20 mL of 0.25% bupivacaine before surgery. No IPACK block will be administered. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Ultrasound-guided adductor canal block will be performed with the participant in the supine position. A linear ultrasound transducer will be placed over the mid-thigh to identify the femoral artery and adjacent saphenous nerve beneath the sartorius muscle. After confirming needle placement and careful aspiration, 20 mL of 0.25% bupivacaine will be injected around the saphenous nerve in 5 mL increments.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Postoperative Pain Intensity Measured by Numeric Rating Scale (NRS)
Prazo: 2, 6, 12, and 24 hours after surgery

Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain), both at rest and during movement (knee flexion greater than 45 degrees). Pain scores will be recorded and compared between the two study groups.

2, 6, 12, and 24 hours after surgery

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Time to First Analgesic Request
Prazo: First 24 hours after surgery

The time from the end of surgery to the first request for postoperative rescue analgesia will be recorded in hours and compared between the two study groups.

First 24 hours after surgery
Postoperative Quality of Recovery Measured by QoR-15 Score
Prazo: 24 hours after surgery

Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better recovery quality. Scores will be compared between the two study groups.

24 hours after surgery
Adverse Effects
Prazo: Up to 24 hours following surgery

Incidence of Block-Related Adverse Effects

Up to 24 hours following surgery
Total Opioid Consumption During the First 24 Hours After Surgery
Prazo: First 24 hours after surgery

Measure and compare the total opioid consumption between the two study groups during the first 24 hours after surgery. Opioid consumption will be recorded and expressed in morphine-equivalent doses (mg).

First 24 hours after surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de dezembro de 2026

Conclusão Primária (Estimado)

31 de maio de 2027

Conclusão do estudo (Estimado)

31 de maio de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

12 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

18 de novembro de 2026

Primeira postagem (Real)

20 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

20 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

18 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Dados/documentos do estudo

  1. Protocolo de estudo
    Identificador de informação: pain.medicine@bmu.ac.bd

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever